| Trial ID: | L3130 |
| Source ID: | NCT00413348
|
| Associated Drug: |
Lactobacillus Acidophilus Ncfm
|
| Title: |
Type 2 Diabetes and the Effect of Probiotics
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Healthy|Endotoxemia
|
| Interventions: |
DRUG: Lactobacillus acidophilus NCFM
|
| Outcome Measures: |
Primary: Change in insulin-resistance|Change in inflammatory response to E. coli endotoxin injection |
|
| Sponsor/Collaborators: |
Sponsor: Rigshospitalet, Denmark | Collaborators: Royal Veterinary and Agricultural University, Denmark
|
| Gender: |
MALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
48
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: PREVENTION
|
| Start Date: |
2006-11
|
| Completion Date: |
2007-12
|
| Results First Posted: |
|
| Last Update Posted: |
2006-12-19
|
| Locations: |
Center of Inflammation and metabolism 7641 and Intensive Care Unit 4131, Rigshospitalet, Copenhagen, DK-2100, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00413348
|
